Life after the lead asset: Advancing an early-stage pipeline
From BioSpace · · 24 min
This plays from the publisher's own server. We do not host a copy.
Description
In this episode of Denatured presented by Arvinas, Jennifer Smith-Parker speaks to Arvinas President and CEO Randy Teel about the strategic discipline and leadership required to successfully refocus a company on an early-stage pipeline after a lead asset is outlicensed, discontinued or otherwise falls away — an inflection point many biotech and pharma companies face, but few navigate effectively.
This episode is presented in partnership with Arvinas (https://www.arvinas.com/).
Host
Jennifer Smith-Parker (https://www.linkedin.com/in/jennifersmithparker/), Director of Insights, BioSpace
Guest
Randy Teel (https://www.linkedin.com/in/randyteel/), President and CEO, Arvinas